LEA29Y (Belatacept) Emory Edmonton Protocol
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
LEA29Y (Belatacept) Emory Edmonton Protocol is a clinical trial[1].
Key Facts
- LEA29Y (Belatacept) Emory Edmonton Protocol is in the country of Canada[2].
- LEA29Y (Belatacept) Emory Edmonton Protocol is in the country of United States[3].
- LEA29Y (Belatacept) Emory Edmonton Protocol's instance of is recorded as clinical trial[4].
- LEA29Y (Belatacept) Emory Edmonton Protocol's start time is recorded as +2008-10-31T00:00:00Z[5].
- LEA29Y (Belatacept) Emory Edmonton Protocol's end time is recorded as +2012-04-30T00:00:00Z[6].
- LEA29Y (Belatacept) Emory Edmonton Protocol's main subject is recorded as diabetes[7].
- LEA29Y (Belatacept) Emory Edmonton Protocol's number of participants is recorded as {'unit': '1', 'amount': '+10'}[8].
- LEA29Y (Belatacept) Emory Edmonton Protocol's title is recorded as Islet Transplantation in Type I Diabetes With LEA29Y (Belatacept) Maintenance Therapy (CIT-04)[9].
- LEA29Y (Belatacept) Emory Edmonton Protocol's short name is recorded as LEEP[10].
- LEA29Y (Belatacept) Emory Edmonton Protocol's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[11].
- LEA29Y (Belatacept) Emory Edmonton Protocol's ClinicalTrials.gov ID is recorded as NCT00468403[12].
- LEA29Y (Belatacept) Emory Edmonton Protocol's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+65'}[13].
- LEA29Y (Belatacept) Emory Edmonton Protocol's research intervention is recorded as abatacept[14].
- LEA29Y (Belatacept) Emory Edmonton Protocol's clinical trial phase is recorded as phase II clinical trial[15].
- LEA29Y (Belatacept) Emory Edmonton Protocol's research site is recorded as Emory University[16].
- LEA29Y (Belatacept) Emory Edmonton Protocol's research site is recorded as University of Alberta[17].
- LEA29Y (Belatacept) Emory Edmonton Protocol's study type is recorded as interventional study[18].